Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$2.15 - $3.5 $105,350 - $171,500
-49,000 Closed
0 $0
Q3 2020

Oct 20, 2020

BUY
$2.77 - $6.17 $135,730 - $302,330
49,000 New
49,000 $140,000
Q1 2020

Apr 17, 2020

SELL
$0.73 - $1.91 $14,600 - $38,200
-20,000 Closed
0 $0
Q4 2019

Jan 16, 2020

BUY
$0.48 - $1.38 $9,600 - $27,599
20,000 New
20,000 $28,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.